[1]
Ravasio, R., Rigo, F., Lattuada, E., Concia, E. and Lanzafame, M. 2016. Economic Evaluation of Nevirapine plus Raltegravir as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1 Infected Patients. Global and Regional Health Technology Assessment. 3, 2 (Jul. 2016), 110–114. DOI:https://doi.org/10.33393/grhta.2016.416.